Home LiteratureArticle Details
PMID: 11438726 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor.

Riewald M, Ruf W

Abstract

The crucial role of cell signaling in hemostasis is clearly established by the action of the downstream coagulation protease thrombin that cleaves platelet-expressed G-protein-coupled protease activated receptors (PARs). Certain PARs are cleaved by the upstream coagulation proteases factor Xa (Xa) and the tissue factor (TF)--factor VIIa (VIIa) complex, but these enzymes are required at high nonphysiological concentrations and show limited recognition specificity for the scissile bond of target PARs. However, defining a physiological mechanism of PAR activation by upstream proteases is highly relevant because of the potent anti-inflammatory in vivo effects of inhibitors of the TF initiation complex. Activation of substrate factor X (X) by the TF--VIIa complex is here shown to produce enhanced cell signaling in comparison to the TF--VIIa complex alone, free Xa, or Xa that is generated in situ by the intrinsic activation complex. Macromolecular assembly of X into a ternary complex of TF--VIIa--X is required for proteolytic conversion to Xa, and product Xa remains transiently associated in a TF--VIIa--Xa complex. By trapping this complex with a unique inhibitor that preserves Xa activity, we directly show that Xa in this ternary complex efficiently activates PAR-1 and -2. These experiments support the concept that proinflammatory upstream coagulation protease signaling is mechanistically coupled and thus an integrated part of the TF--VIIa-initiated coagulation pathway, rather than a late event during excessive activation of coagulation and systemic generation of proteolytic activity.

MeSH Terms
Animals Blood Coagulation CHO Cells Cricetinae Protein Binding Protein Conformation Signal Transduction Thrombin/chemistry,metabolism Thromboplastin/chemistry,metabolism
Chemicals
Thromboplastin Thrombin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Riewald M
Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Ruf W
References (42)
42 references, click to expand
  1. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway.
    J Cell Biol. 1996 Apr;133(2):293-304 PMID: 8609163
  2. Exosite interactions determine the affinity of factor X for the extrinsic Xase complex.
    J Biol Chem. 2000 Sep 15;275(37):28826-33 PMID: 10889208
  3. The effect of leukocyte elastase on tissue factor pathway inhibitor.
    Blood. 1992 Apr 1;79(7):1712-9 PMID: 1558967
  4. Coagulation factors VII and X induce Ca2+ oscillations in Madin-Darby canine kidney cells only when proteolytically active.
    J Biol Chem. 1996 Nov 15;271(46):29034-42 PMID: 8910556
  5. Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis.
    J Clin Invest. 1998 Apr 1;101(7):1372-8 PMID: 9525979
  6. Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor.
    J Clin Invest. 1999 Nov;104(9):1213-21 PMID: 10545520
  7. An anti-tissue factor monoclonal antibody which inhibits TF.VIIa complex is a potent anticoagulant in plasma.
    Thromb Haemost. 1991 Nov 1;66(5):529-33 PMID: 1803616
  8. Allosteric regulation of the cofactor-dependent serine protease coagulation factor VIIa.
    Trends Cardiovasc Med. 1998 Nov;8(8):350-6 PMID: 14987549
  9. Effect of soluble tissue factor on the kinetic mechanism of factor VIIa: enhancement of p-guanidinobenzoate substrate hydrolysis.
    Biochemistry. 1996 Jun 4;35(22):7100-6 PMID: 8679536
  10. Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin?
    Blood. 2000 Feb 15;95(4):1113-6 PMID: 10666178
  11. Binding of factor VIIa to tissue factor on keratinocytes induces gene expression.
    J Biol Chem. 2000 Mar 3;275(9):6580-5 PMID: 10692465
  12. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor.
    J Biol Chem. 1998 Mar 13;273(11):6228-32 PMID: 9497347
  13. Macromolecular substrate affinity for the tissue factor-factor VIIa complex is independent of scissile bond docking.
    J Biol Chem. 1999 Aug 20;274(34):24171-5 PMID: 10446191
  14. Factor VIIa and thrombin induce the expression of Cyr61 and connective tissue growth factor, extracellular matrix signaling proteins that could act as possible downstream mediators in factor VIIa x tissue factor-induced signal transduction.
    J Biol Chem. 2000 May 12;275(19):14632-41 PMID: 10799550
  15. Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor.
    J Biol Chem. 1998 Feb 20;273(8):4378-86 PMID: 9468488
  16. Importance of factor VIIa Gla-domain residue Arg-36 for recognition of the macromolecular substrate factor X Gla-domain.
    Biochemistry. 1999 Feb 16;38(7):1957-66 PMID: 10026279
  17. Characterisation of a novel series of aprotinin-derived anticoagulants. I. In vitro and pharmacological properties.
    Thromb Haemost. 1995 Aug;74(2):646-54 PMID: 8585001
  18. Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2.
    Eur J Biochem. 1995 Aug 15;232(1):84-9 PMID: 7556175
  19. Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1.
    J Biol Chem. 2000 May 5;275(18):13502-9 PMID: 10788464
  20. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
    Proc Natl Acad Sci U S A. 2000 May 9;97(10):5255-60 PMID: 10805786
  21. The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. Comparison with the thrombin receptor.
    J Biol Chem. 1996 Jun 21;271(25):14910-5 PMID: 8663011
  22. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.
    J Clin Invest. 1993 Jun;91(6):2850-60 PMID: 8514893
  23. Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli.
    Blood. 1998 Mar 1;91(5):1609-15 PMID: 9473226
  24. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody.
    Circ Shock. 1991 Mar;33(3):127-34 PMID: 2044206
  25. Thrombin signalling and protease-activated receptors.
    Nature. 2000 Sep 14;407(6801):258-64 PMID: 11001069
  26. Anticoagulant repertoire of the hookworm Ancylostoma caninum.
    Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2149-54 PMID: 8700900
  27. Tissue factor pathway inhibitor and the revised theory of coagulation.
    Annu Rev Med. 1995;46:103-12 PMID: 7598447
  28. Influence of cofactor binding and active site occupancy on the conformation of the macromolecular substrate exosite of factor VIIa.
    J Mol Biol. 1998 Apr 10;277(4):959-71 PMID: 9545384
  29. Coagulation factors VIIa and Xa induce cell signaling leading to up-regulation of the egr-1 gene.
    J Biol Chem. 1999 Nov 5;274(45):32225-33 PMID: 10542260
  30. Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2.
    J Biol Chem. 2001 Mar 30;276(13):10063-71 PMID: 11139576
  31. Urea inducibility of egr-1 in murine inner medullary collecting duct cells is mediated by the serum response element and adjacent Ets motifs.
    J Biol Chem. 1996 May 31;271(22):12903-8 PMID: 8662677
  32. DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage.
    Blood. 1991 Jul 15;78(2):364-8 PMID: 2070073
  33. Attenuation of tissue thrombosis and hemorrhage by ala-TFPI does not account for its protection against E. coli--a comparative study of treated and untreated non-surviving baboons challenged with LD100 E. coli.
    Thromb Haemost. 1998 May;79(5):1048-53 PMID: 9609245
  34. A model for the tissue factor pathway to thrombin. I. An empirical study.
    J Biol Chem. 1994 Sep 16;269(37):23357-66 PMID: 8083241
  35. Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1.
    Blood. 2001 May 15;97(10):3109-16 PMID: 11342437
  36. Factor Xa activates endothelial cells by a receptor cascade between EPR-1 and PAR-2.
    Arterioscler Thromb Vasc Biol. 2000 Nov;20(11):E107-12 PMID: 11073863
  37. Antibody mapping of tissue factor implicates two different exon-encoded regions in function.
    Biochem J. 1991 Sep 15;278 ( Pt 3):729-33 PMID: 1716883
  38. Receptor-activating peptides distinguish thrombin receptor (PAR-1) and protease activated receptor 2 (PAR-2) mediated hemodynamic responses in vivo.
    Can J Physiol Pharmacol. 1998 Jan;76(1):16-25 PMID: 9564545
  39. Efficacy and safety of recombinant human activated protein C for severe sepsis.
    N Engl J Med. 2001 Mar 8;344(10):699-709 PMID: 11236773
  40. Comparison of recombinant tissue factor pathway inhibitors expressed in human SK hepatoma, mouse C127, baby hamster kidney, and Chinese hamster ovary cells.
    Thromb Haemost. 1992 Jul 6;68(1):54-9 PMID: 1325078
  41. Regulation of factor VIIIa by human activated protein C and protein S: inactivation of cofactor in the intrinsic factor Xase.
    Blood. 2000 Mar 1;95(5):1714-20 PMID: 10688829
  42. Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation.
    J Biol Chem. 2000 Sep 1;275(35):27123-8 PMID: 10859319
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2001-07-03
Pages
7742-7
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC35412
Subset
IM
Grants
NHLBI NIH HHS · P01 HL016411 · United States
NHLBI NIH HHS · R01 HL048752 · United States
NHLBI NIH HHS · HL 16411 · United States
NHLBI NIH HHS · HL 48752 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com